Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS
Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors eva...
Gespeichert in:
Veröffentlicht in: | Anesthesiology (Philadelphia) 1999-12, Vol.91 (6), p.1577-1586 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1586 |
---|---|
container_issue | 6 |
container_start_page | 1577 |
container_title | Anesthesiology (Philadelphia) |
container_volume | 91 |
creator | ULLRICH, R LORBER, C RÖDER, G URAK, G FARYNIAK, B SLADEN, R. N GERMANN, P |
description | Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors evaluated the effect of a combined therapeutic approach on the survival of patients with acute respiratory distress syndrome, when treated according to a strict algorithm.
During a 2.5-yr period, 84 patients with acute respiratory distress syndrome were assigned to a standardized treatment protocol. Data analysis was performed by retrospective review of patient charts. Patients were treated using a stepwise treatment algorithm of pressure-controlled ventilation (peak airway pressure < 35 cm H2O), positive end-expiratory pressure (PEEP; 12-15 cm H2O), permissive hypercapnia, inhaled nitric oxide (5-20 ppm), and prone positioning. These interventions were termed "conventional therapy." Response to treatment was defined as a more than 20% increase in arterial oxygen tension (PaO2). Nonresponders were triaged to extracorporeal membrane oxygenation.
The overall survival rate was 80%. All patients received conventional therapy up to 96 h; 71 responded to conventional therapy and 59 survived (83%). Thirteen patients (15%) did not respond to conventional therapy and underwent extracorporeal membrane oxygenation; 8 of these patients (62%) survived. For the group, the mean admission lung injury score was 3.3+/-0.5, the PaO2/fractional inspired oxygen tension (F(I)O2) ratio was 96+/-45, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score was 18+/-6.
The 80% overall survival rate achieved in this group of patients with severe acute respiratory distress syndrome may in part reflect the additive beneficial effects of combined treatment methods, such as airway pressure control, nitric oxide inhalation, prone position, and early triage of nonresponders to extracorporeal membrane oxygenation. |
doi_str_mv | 10.1097/00000542-199912000-00007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69354924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69354924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-7d6fda0a135f43af5bc137be03304a8b11ba9d3cdb0cca5f186db1429b30fb023</originalsourceid><addsrcrecordid>eNpNkdtq3DAQhkVISbZpXiHoooQU4kYHa21dhm16gJRA2l6b0SmrYluupKW7z9SXrJzdHnQjZvj-f0b6EcKUvKVENjdkPqJmFZVSUlaKau40R2hBBWsrShtxjBalxStOGDtFL1P6PhOCtyfolBIhWyGbBfq1CmOOoe-tweDjT9jhKdqUNtHivLYRpt01Hn2OXuOw9cZiP66hh-zDeF3QMFo8heT3NYwG222OoEOcQrTQ48EOKkKhwnb3ZMdnIb66W31-eIMhYR2GqXiMOeHgir7YZ_sUIc_7TMUf9BrngG8f3315hV446JM9P9xn6Nv7u6-rj9X9w4dPq9v7SnNJctWYpTNAgHLhag5OKE15oyzhnNTQKkoVSMO1UURrEI62S6NozaTixCnC-Bm63PuW8T82NuVu8Enbvi_PCJvULSUXtWR1Ads9qGNIKVrXTdEPEHcdJd0cVPcnqO5vUM-tpkgvDjM2arDmP-E-mQK8PgCQNPSu_KH26R_HCKeU89-PBJ7i</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69354924</pqid></control><display><type>article</type><title>Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>ULLRICH, R ; LORBER, C ; RÖDER, G ; URAK, G ; FARYNIAK, B ; SLADEN, R. N ; GERMANN, P</creator><creatorcontrib>ULLRICH, R ; LORBER, C ; RÖDER, G ; URAK, G ; FARYNIAK, B ; SLADEN, R. N ; GERMANN, P</creatorcontrib><description>Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors evaluated the effect of a combined therapeutic approach on the survival of patients with acute respiratory distress syndrome, when treated according to a strict algorithm.
During a 2.5-yr period, 84 patients with acute respiratory distress syndrome were assigned to a standardized treatment protocol. Data analysis was performed by retrospective review of patient charts. Patients were treated using a stepwise treatment algorithm of pressure-controlled ventilation (peak airway pressure < 35 cm H2O), positive end-expiratory pressure (PEEP; 12-15 cm H2O), permissive hypercapnia, inhaled nitric oxide (5-20 ppm), and prone positioning. These interventions were termed "conventional therapy." Response to treatment was defined as a more than 20% increase in arterial oxygen tension (PaO2). Nonresponders were triaged to extracorporeal membrane oxygenation.
The overall survival rate was 80%. All patients received conventional therapy up to 96 h; 71 responded to conventional therapy and 59 survived (83%). Thirteen patients (15%) did not respond to conventional therapy and underwent extracorporeal membrane oxygenation; 8 of these patients (62%) survived. For the group, the mean admission lung injury score was 3.3+/-0.5, the PaO2/fractional inspired oxygen tension (F(I)O2) ratio was 96+/-45, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score was 18+/-6.
The 80% overall survival rate achieved in this group of patients with severe acute respiratory distress syndrome may in part reflect the additive beneficial effects of combined treatment methods, such as airway pressure control, nitric oxide inhalation, prone position, and early triage of nonresponders to extracorporeal membrane oxygenation.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-199912000-00007</identifier><identifier>PMID: 10598597</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Administration, Inhalation ; Adolescent ; Adult ; Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; APACHE ; Biological and medical sciences ; Child ; Combined Modality Therapy ; Electrocardiography ; Emergency and intensive respiratory care ; Extracorporeal Membrane Oxygenation ; Female ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Nitric Oxide - administration & dosage ; Nitric Oxide - therapeutic use ; Prone Position - physiology ; Respiration, Artificial ; Respiratory Distress Syndrome, Adult - physiopathology ; Respiratory Distress Syndrome, Adult - therapy ; Respiratory Function Tests ; Survival Analysis</subject><ispartof>Anesthesiology (Philadelphia), 1999-12, Vol.91 (6), p.1577-1586</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-7d6fda0a135f43af5bc137be03304a8b11ba9d3cdb0cca5f186db1429b30fb023</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1203113$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10598597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ULLRICH, R</creatorcontrib><creatorcontrib>LORBER, C</creatorcontrib><creatorcontrib>RÖDER, G</creatorcontrib><creatorcontrib>URAK, G</creatorcontrib><creatorcontrib>FARYNIAK, B</creatorcontrib><creatorcontrib>SLADEN, R. N</creatorcontrib><creatorcontrib>GERMANN, P</creatorcontrib><title>Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors evaluated the effect of a combined therapeutic approach on the survival of patients with acute respiratory distress syndrome, when treated according to a strict algorithm.
During a 2.5-yr period, 84 patients with acute respiratory distress syndrome were assigned to a standardized treatment protocol. Data analysis was performed by retrospective review of patient charts. Patients were treated using a stepwise treatment algorithm of pressure-controlled ventilation (peak airway pressure < 35 cm H2O), positive end-expiratory pressure (PEEP; 12-15 cm H2O), permissive hypercapnia, inhaled nitric oxide (5-20 ppm), and prone positioning. These interventions were termed "conventional therapy." Response to treatment was defined as a more than 20% increase in arterial oxygen tension (PaO2). Nonresponders were triaged to extracorporeal membrane oxygenation.
The overall survival rate was 80%. All patients received conventional therapy up to 96 h; 71 responded to conventional therapy and 59 survived (83%). Thirteen patients (15%) did not respond to conventional therapy and underwent extracorporeal membrane oxygenation; 8 of these patients (62%) survived. For the group, the mean admission lung injury score was 3.3+/-0.5, the PaO2/fractional inspired oxygen tension (F(I)O2) ratio was 96+/-45, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score was 18+/-6.
The 80% overall survival rate achieved in this group of patients with severe acute respiratory distress syndrome may in part reflect the additive beneficial effects of combined treatment methods, such as airway pressure control, nitric oxide inhalation, prone position, and early triage of nonresponders to extracorporeal membrane oxygenation.</description><subject>Administration, Inhalation</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>APACHE</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Combined Modality Therapy</subject><subject>Electrocardiography</subject><subject>Emergency and intensive respiratory care</subject><subject>Extracorporeal Membrane Oxygenation</subject><subject>Female</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nitric Oxide - administration & dosage</subject><subject>Nitric Oxide - therapeutic use</subject><subject>Prone Position - physiology</subject><subject>Respiration, Artificial</subject><subject>Respiratory Distress Syndrome, Adult - physiopathology</subject><subject>Respiratory Distress Syndrome, Adult - therapy</subject><subject>Respiratory Function Tests</subject><subject>Survival Analysis</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkdtq3DAQhkVISbZpXiHoooQU4kYHa21dhm16gJRA2l6b0SmrYluupKW7z9SXrJzdHnQjZvj-f0b6EcKUvKVENjdkPqJmFZVSUlaKau40R2hBBWsrShtxjBalxStOGDtFL1P6PhOCtyfolBIhWyGbBfq1CmOOoe-tweDjT9jhKdqUNtHivLYRpt01Hn2OXuOw9cZiP66hh-zDeF3QMFo8heT3NYwG222OoEOcQrTQ48EOKkKhwnb3ZMdnIb66W31-eIMhYR2GqXiMOeHgir7YZ_sUIc_7TMUf9BrngG8f3315hV446JM9P9xn6Nv7u6-rj9X9w4dPq9v7SnNJctWYpTNAgHLhag5OKE15oyzhnNTQKkoVSMO1UURrEI62S6NozaTixCnC-Bm63PuW8T82NuVu8Enbvi_PCJvULSUXtWR1Ads9qGNIKVrXTdEPEHcdJd0cVPcnqO5vUM-tpkgvDjM2arDmP-E-mQK8PgCQNPSu_KH26R_HCKeU89-PBJ7i</recordid><startdate>19991201</startdate><enddate>19991201</enddate><creator>ULLRICH, R</creator><creator>LORBER, C</creator><creator>RÖDER, G</creator><creator>URAK, G</creator><creator>FARYNIAK, B</creator><creator>SLADEN, R. N</creator><creator>GERMANN, P</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991201</creationdate><title>Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS</title><author>ULLRICH, R ; LORBER, C ; RÖDER, G ; URAK, G ; FARYNIAK, B ; SLADEN, R. N ; GERMANN, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-7d6fda0a135f43af5bc137be03304a8b11ba9d3cdb0cca5f186db1429b30fb023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Administration, Inhalation</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>APACHE</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Combined Modality Therapy</topic><topic>Electrocardiography</topic><topic>Emergency and intensive respiratory care</topic><topic>Extracorporeal Membrane Oxygenation</topic><topic>Female</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nitric Oxide - administration & dosage</topic><topic>Nitric Oxide - therapeutic use</topic><topic>Prone Position - physiology</topic><topic>Respiration, Artificial</topic><topic>Respiratory Distress Syndrome, Adult - physiopathology</topic><topic>Respiratory Distress Syndrome, Adult - therapy</topic><topic>Respiratory Function Tests</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ULLRICH, R</creatorcontrib><creatorcontrib>LORBER, C</creatorcontrib><creatorcontrib>RÖDER, G</creatorcontrib><creatorcontrib>URAK, G</creatorcontrib><creatorcontrib>FARYNIAK, B</creatorcontrib><creatorcontrib>SLADEN, R. N</creatorcontrib><creatorcontrib>GERMANN, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ULLRICH, R</au><au>LORBER, C</au><au>RÖDER, G</au><au>URAK, G</au><au>FARYNIAK, B</au><au>SLADEN, R. N</au><au>GERMANN, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>1999-12-01</date><risdate>1999</risdate><volume>91</volume><issue>6</issue><spage>1577</spage><epage>1586</epage><pages>1577-1586</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors evaluated the effect of a combined therapeutic approach on the survival of patients with acute respiratory distress syndrome, when treated according to a strict algorithm.
During a 2.5-yr period, 84 patients with acute respiratory distress syndrome were assigned to a standardized treatment protocol. Data analysis was performed by retrospective review of patient charts. Patients were treated using a stepwise treatment algorithm of pressure-controlled ventilation (peak airway pressure < 35 cm H2O), positive end-expiratory pressure (PEEP; 12-15 cm H2O), permissive hypercapnia, inhaled nitric oxide (5-20 ppm), and prone positioning. These interventions were termed "conventional therapy." Response to treatment was defined as a more than 20% increase in arterial oxygen tension (PaO2). Nonresponders were triaged to extracorporeal membrane oxygenation.
The overall survival rate was 80%. All patients received conventional therapy up to 96 h; 71 responded to conventional therapy and 59 survived (83%). Thirteen patients (15%) did not respond to conventional therapy and underwent extracorporeal membrane oxygenation; 8 of these patients (62%) survived. For the group, the mean admission lung injury score was 3.3+/-0.5, the PaO2/fractional inspired oxygen tension (F(I)O2) ratio was 96+/-45, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score was 18+/-6.
The 80% overall survival rate achieved in this group of patients with severe acute respiratory distress syndrome may in part reflect the additive beneficial effects of combined treatment methods, such as airway pressure control, nitric oxide inhalation, prone position, and early triage of nonresponders to extracorporeal membrane oxygenation.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>10598597</pmid><doi>10.1097/00000542-199912000-00007</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-3022 |
ispartof | Anesthesiology (Philadelphia), 1999-12, Vol.91 (6), p.1577-1586 |
issn | 0003-3022 1528-1175 |
language | eng |
recordid | cdi_proquest_miscellaneous_69354924 |
source | MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Administration, Inhalation Adolescent Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy APACHE Biological and medical sciences Child Combined Modality Therapy Electrocardiography Emergency and intensive respiratory care Extracorporeal Membrane Oxygenation Female Humans Intensive care medicine Male Medical sciences Middle Aged Nitric Oxide - administration & dosage Nitric Oxide - therapeutic use Prone Position - physiology Respiration, Artificial Respiratory Distress Syndrome, Adult - physiopathology Respiratory Distress Syndrome, Adult - therapy Respiratory Function Tests Survival Analysis |
title | Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A47%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Controlled%20airway%20pressure%20therapy,%20nitric%20oxide%20inhalation,%20prone%20position,%20and%20extracorporeal%20membrane%20oxygenation%20(ECMO)%20as%20components%20of%20an%20integrated%20approach%20to%20ARDS&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=ULLRICH,%20R&rft.date=1999-12-01&rft.volume=91&rft.issue=6&rft.spage=1577&rft.epage=1586&rft.pages=1577-1586&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-199912000-00007&rft_dat=%3Cproquest_cross%3E69354924%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69354924&rft_id=info:pmid/10598597&rfr_iscdi=true |